Written by Healing Sky Editorial Team. Clinically reviewed by Cynthia Abraham D.O.
Catatonia can look like a person has simply stopped, stopped speaking, stopped moving, stopped responding to the people around them. It can also look like the opposite: uncontrolled, purposeless agitation that seems to come from nowhere. Both presentations are expressions of the same serious neuropsychiatric condition, and both are treatable. Families who recognize the signs early and get a prompt evaluation give their loved one the best chance at a fast recovery.
Catatonia produces a cluster of behavioral and movement symptoms that can arise in people with mood disorders, schizophrenia spectrum disorders, neurodevelopmental conditions, neurological diseases, and certain medical or substance-related states. The diagnosis requires multiple characteristic signs to appear together, and it is more common in clinical settings than many providers recognize.
The formal diagnostic criteria for catatonia include the following signs, which clinicians assess together rather than in isolation:
A person with catatonia will typically display several of these signs, and the pattern can shift over hours or days.
In daily life, family members often notice something is wrong before a formal diagnosis is made. A person may start whispering before stopping speech entirely, or stay frozen in one position for long stretches as though unable to move. They may refuse food, water, and medication even when encouraged, or hold rigid postures, arms extended, neck bent, back curved, for minutes to hours. Some people perform the same action on a loop, imitate everything another person says or does, or cycle between stillness in the morning and intense agitation later in the day. Without prompt treatment, catatonia can lead to dehydration, malnutrition, blood clots, pressure sores, and muscle breakdown.
Clinicians recognize three main patterns. Retarded (hypokinetic) catatonia is characterized by reduced movement, silence, and immobility. The person may stare, resist assistance, maintain abnormal postures, and stop eating or drinking. Excited (hyperkinetic) catatonia presents as uncontrolled, purposeless high-energy movement, constant activity, fragmented speech, echolalia, and extreme restlessness that creates safety risks. Malignant catatonia is a medical emergency: it combines fever, autonomic instability (rapid heart rate, unstable blood pressure, excessive sweating), severe agitation, and confusion, and it worsens rapidly without hospital-level care.
The following signs require immediate evaluation at an emergency facility:
In the United States, call 911 for medical crises. The Suicide and Crisis Lifeline is available by calling or texting 988.
Catatonia functions as a final common pathway through which the brain expresses distress from a range of underlying causes. The balance between GABA, glutamate, and dopamine appears to play a central role, and that balance can be disrupted by psychiatric conditions, medical illness, and neurological disorders alike.
Mood disorders are among the most common associations. Severe depression can present with catatonic features, and bipolar disorder can produce catatonia during manic, mixed, or depressive phases. Schizophrenia spectrum disorders are a recognized cause, though in current clinical practice mood disorders account for more catatonia cases. Autism spectrum disorder is another context in which catatonia can emerge, particularly during periods of stress or medical illness.
On the medical and neurological side, autoimmune encephalitis (including anti-NMDA receptor encephalitis), seizure disorders and postictal states, stroke, Parkinson's disease, traumatic brain injury, infections, high fevers, systemic inflammatory states, and metabolic or endocrine problems such as electrolyte changes or thyroid disease can all trigger catatonia. Abrupt benzodiazepine withdrawal is a recognized precipitant in vulnerable individuals. Certain antipsychotics can worsen catatonia or create a clinical picture that overlaps with neuroleptic malignant syndrome, and stimulants, steroids, and other substances are occasionally implicated as well.
Diagnosis depends on direct clinical observation and a thorough physical assessment. Clinicians look for multiple characteristic signs appearing together and rule out other dangerous conditions that can look similar.
At the bedside, the clinician observes whether the person speaks spontaneously, follows simple commands, maintains fixed positions, resists movement, or shows repetitive purposeless actions. Waxy flexibility and catalepsy are assessed by safely repositioning a limb and observing whether it holds. Negativism is tested with simple tasks such as opening the mouth. The Bush-Francis Catatonia Rating Scale helps clinicians track symptom severity and monitor treatment response over time.
The lorazepam challenge is both a diagnostic tool and the start of treatment: a small dose of lorazepam is given under close observation, and a quick, clear improvement in speech, movement, or cooperation supports the diagnosis. A lack of response does not rule catatonia out. The medical workup looks for infection, dehydration, metabolic disorders, thyroid problems, and muscle damage through blood tests, urine toxicology, and a medication review. Brain imaging or EEG is added when seizures, stroke, or encephalitis are possible. Autoimmune and infectious testing follows when the clinical picture suggests it.
Conditions that can resemble catatonia include delirium, severe depression without catatonic features, nonconvulsive status epilepticus, akinetic mutism, locked-in syndrome, advanced Parkinsonism, and neuroleptic malignant syndrome. NMS is particularly important to distinguish because it develops in the context of specific medication use and requires a different treatment approach. Not every patient needs every test; the workup is guided by the timeline, current medications, and the full clinical picture.
Catatonia is among the most treatment-responsive conditions in psychiatry. The core principles are to treat catatonia itself first, provide protective care to prevent complications, and identify and correct the underlying cause.
Most patients require hospitalization for hydration, nutrition support, and protection from harm. Nursing care focuses on preventing blood clots, pressure injuries, and aspiration. Lorazepam is the first-line medication; it works by releasing the motor blockage that underlies catatonia, and improvement in speech, movement, and cooperation can appear quickly. Doses are adjusted to relieve catatonia without causing excessive sedation. The same test dose used in the lorazepam challenge initiates treatment, and scheduled doses follow for patients who respond, with ongoing monitoring of vital signs, hydration, and functional status.
Electroconvulsive therapy (ECT) is used when benzodiazepines provide insufficient relief, when symptoms reach dangerous levels, or when rapid recovery is essential. It is administered under brief anesthesia, and patients typically need a short series of sessions spanning days to weeks. ECT has a strong evidence base for catatonia and is not an experimental or last-resort option.
Treating the underlying condition runs in parallel: mood stabilization, antidepressant approaches, management of autoimmune encephalitis or infection, and correction of metabolic problems. Neurology, internal medicine, and critical care teams are brought in when needed. Certain antipsychotics can worsen catatonia or precipitate NMS, so treatment for psychosis is generally deferred until catatonia has improved, and then started cautiously with benzodiazepines as a supplement. Amantadine or memantine may be added to modify glutamate pathways in some cases, and zolpidem is occasionally used briefly in specific presentations.
Recovery does not follow a predictable timeline. Energy, appetite, and movement typically return before motivation does. Physical therapy and structured daily routines help patients reach their final recovery milestones.
Catatonia occurs at every age, but the presentation and risk factors differ. In children and adolescents, it frequently develops alongside mood disorders, autism spectrum disorder, and autoimmune encephalitis. Echolalia, stereotypies, and agitation tend to appear more often than posturing. Young patients need prompt medical workup because the underlying causes often require specialized treatment.
In older adults, medical triggers and medication side effects become more prominent contributors. Delirium and dementia share overlapping features with catatonia, so the assessment requires particular care to distinguish them. The risks of blood clots and muscle breakdown escalate quickly in this age group, making early mobilization and hydration especially important. Family involvement in observing changes, sharing history, and supporting rehydration and gentle routines can accelerate recovery at any age.
Several persistent misconceptions delay diagnosis and treatment. Catatonia is not exclusive to schizophrenia, mood disorders account for more cases in most clinical settings, and a catatonia diagnosis does not imply a schizophrenia diagnosis. It is not rare; it is frequently encountered in medical facilities but often goes unrecognized. The person is not being willfully defiant: catatonia reflects a brain-based inability to initiate actions, not a choice. First-line treatment is not extreme, lorazepam is a standard medication, and ECT is administered safely under anesthesia. And most people do not experience repeated episodes: when the underlying condition is treated and follow-up is consistent, a single treatable episode is the typical outcome.
Family members play a real role in early recognition, even though medical treatment is essential for management. Keeping detailed observations is the most useful thing a family member can do: note when speech diminishes, when meals are skipped, and when unusual body positions appear, and track changes across the full day since catatonia often shifts between morning and evening.
Reducing stimulation helps, a calm environment with dimmed lights and one quiet voice can decrease agitation. Brief, direct instructions ("Take a sip," "Stand up") with enough time for a response are more effective than complex requests. Encouraging small wins such as a few sips of water through a straw, soft food, or a short assisted walk supports hydration and function. Gentle guidance is appropriate; if the person shows intense resistance or rigidity, medical assistance is needed rather than force.
Bringing complete information to the evaluation matters: current medications, past illnesses, substance use, autoimmune conditions, seizure history, and any previous responses to benzodiazepines or ECT all inform the clinical picture. If the person cannot eat, drink, use the toilet, or move safely at home, the situation requires emergency evaluation rather than an outpatient appointment.
After the acute episode, the focus shifts to maintaining wellness and reducing the risk of recurrence. Benzodiazepines are tapered gradually under close observation rather than stopped abruptly. Patients with mood or psychotic disorders need to remain consistent with their underlying treatments, and sudden medication changes should be avoided. The combination of abrupt medication discontinuation, severe sleep deprivation, infections, and acute stress are recognized relapse triggers.
Early warning signs to watch for include slowed speech, reduced eating, new posturing, and increased repetitive movements. Practical supports include consistent hydration, regular meals, and light physical activity. Physical and occupational therapy are indicated for patients who developed stiffness or deconditioning during the episode. A designated family member or clinician should serve as the point person for detecting changes and coordinating care. Having a contingency plan in place, including contact information, preferred treatment locations, and a record of what worked previously (such as lorazepam providing rapid relief), reduces delays if symptoms return.
Most people return to their baseline level of functioning, including school, work, and social relationships, with consistent follow-up.
Healing Sky can connect individuals and families with a provider who offers thorough catatonia evaluations and prompt treatment. Providers in the Healing Sky network can support early detection of catatonia and identification of similar conditions, evidence-based treatment starting with benzodiazepines and including ECT referral when needed, coordination with primary care, neurology, and medical teams to identify and address underlying causes, and individualized relapse prevention planning aimed at long-term stability.
If catatonia symptoms appear in yourself or a loved one, contact Healing Sky to be matched with a provider who can help.
Medically reviewed by Cynthia Abraham, D.O.
Read More
(NA)
Read More
(NA)
Read More
(NA)
Sign up now to get unrestricted access to Healing Sky's online mental health directory, resources, and more!
Sign up now
